Spontaneous atherosclerosis in the proximal aorta of LPA transgenic mice on a normal diet

Atherosclerosis

Volumn 163, Issue 1, 2002, Pages 99-104

  Berg, Kåre ^a,b   Svindland, Aud ^b   Smith, Adrian J ^c   Lawn, Richard M ^d   Djurovic, Srdjan ^b   Aleström, Annette ^a   Aleström, Peter ^c   Eliassen, Knut ^c  

^a UNIVERSITY OF OSLO   (Norway)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^c NORWEGIAN UNIVERSITY OF LIFE SCIENCES   (Norway)

^d CV THERAPEUTICS INC   (United States)

Author keywords

Atherosclerosis; LPA lipoprotein; Transgenic mice

Indexed keywords

LIPOPROTEIN A; DNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ATHEROSCLEROSIS; ARTICLE; CONTROLLED STUDY; DIET; FAT CONTENT; FEMALE; LIPID DIET; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE; ANIMAL; ARTERIOSCLEROSIS; COMPARATIVE STUDY; CULTURE TECHNIQUE; DISEASE MODEL; GENETICS; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PATHOLOGY; POLYMERASE CHAIN REACTION; PROBABILITY; REFERENCE VALUE; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; THORACIC AORTA;

ANIMALS; AORTA, THORACIC; ARTERIOSCLEROSIS; BASE SEQUENCE; CULTURE TECHNIQUES; DIET; DISEASE MODELS, ANIMAL; DNA; FEMALE; LIPOPROTEIN(A); MALE; MICE; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; PROBABILITY; REFERENCE VALUES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

EID: 0036015989     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(01)00772-9     Document Type: Article

References (25)

1. A new serum type system in man - The Lp system
2. The Lp system
3. Genetics of the Lp system
4. CDNA sequence of human apolipoprotein (a) is homologous to plasminogen
5. Genetic linkage between lipoprotein(a) phenotype and a DNA polymorphism in the plasminogen gene
6. Close linkage between Lp(a) lipoprotein and plasminogen
7. How often has Lp(a) evolved?
8. 1-lipoprotein in patients with coronary heart disease
9. Lp(a) lipoprotein: A monogenic risk factor for cardiovascular disease
10. Lp(a) lipoprotein and risk of atherosclerotic/thrombotic disease
11. Epidemiology of Lp(a) lipoprotein: Its role in atherosclerotic/thrombotic disease
12. Atherogenesis in transgenic mice expressing human apolipoprotein(a)
13. Relative contributions of apolipoprotein(a) and apolipoprotein-B to the development of fatty lesions in the proximal aorta of mice
14. Low density lipoprotein receptor-negative mice expressing human apolipoprotein B-100 develop complex atherosclerotic lesions on a chow diet: No accentuation by apolipoprotein(a)
15. Prevention of cardiovascular and renal pathology of aging by the advanced glycation inhibitor aminoguanidine
16. Reconstitution of lipoprotein(a) by infusion of human low density lipoprotein into transgenic mice expressing human apolipoprotein(a)
17. Atherosclerosis susceptibility differences among progenitors of recombinant inbred strains of mice
18. Histopathology of arterial lesions in LPA transgenic mice on cholesterol-enriched chow
19. Lp(a) lipoprotein level predicts survival and major coronary events in the Scandinavian Simvastatin Survival Study
20. Expression of human apolipoprotein B and assembly of lipoprotein(a) in transgenic mice
21. Atherogenesis in transgenic mice with human apolipoprotein B and lipoprotein (a)
22. Interaction of apolipoprotein(a) with apolipoprotein B-containing lipoproteins
23. Lipoprotein(a) in the arterial wall
24. Morphological detection and quantification of lipoprotein(a) deposition in atheromatous lesions of human aorta and coronary arteries
25. Detection and quantification of lipoprotein(a) in the arterial wall of 107 coronary bypass patients